PQ 521
521. Deputy Brian Stanley asked the Minister for Health if her Department has assessed the impact on patients, particularly those with neurological, developmental, or sleep-related conditions, of melatonin and magnesium not being covered under the long-term illness scheme; and if she will make a statement on the matter. [35831/26]
Introduced
14 May 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
14 May 2026
Summary
521. Deputy Brian Stanley asked the Minister for Health if her Department has assessed the impact on patients, particularly those with neurological, developmental, or sleep-related conditions, of melatonin and magnesium not being covered under the long-term illness scheme; and if she will make a statement on the matter. [35831/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 14 May 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-05-14/521/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-05-14/pq_521